DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,578,284 | -1.6% | 11,145 | +5.5% | 0.12% | -10.8% |
| Q3 2023 | $2,619,687 | +2.9% | 10,559 | -0.5% | 0.13% | +4.0% |
| Q2 2023 | $2,546,640 | -8.2% | 10,611 | -3.6% | 0.12% | -14.4% |
| Q1 2023 | $2,775,464 | +97353.1% | 11,012 | +2.6% | 0.15% | -8.8% |
| Q4 2022 | $2,848 | -99.9% | 10,728 | +8.9% | 0.16% | +5.3% |
| Q3 2022 | $2,545,000 | +12.7% | 9,855 | +10.6% | 0.15% | +20.6% |
| Q2 2022 | $2,259,000 | -9.9% | 8,910 | +4.2% | 0.13% | +7.7% |
| Q1 2022 | $2,508,000 | -6.7% | 8,550 | +4.7% | 0.12% | -0.8% |
| Q4 2021 | $2,688,000 | +13.5% | 8,169 | +5.0% | 0.12% | +7.3% |
| Q3 2021 | $2,368,000 | +10.9% | 7,780 | -2.3% | 0.11% | +10.0% |
| Q2 2021 | $2,136,000 | +20.9% | 7,961 | +1.4% | 0.10% | +12.4% |
| Q1 2021 | $1,767,000 | -4.0% | 7,853 | -5.3% | 0.09% | -10.1% |
| Q4 2020 | $1,841,000 | +3.1% | 8,289 | -0.0% | 0.10% | -10.0% |
| Q3 2020 | $1,786,000 | +7.7% | 8,292 | -11.6% | 0.11% | +0.9% |
| Q2 2020 | $1,659,000 | +19.9% | 9,383 | -6.2% | 0.11% | -0.9% |
| Q1 2020 | $1,384,000 | -4.9% | 10,005 | +5.6% | 0.11% | +22.2% |
| Q4 2019 | $1,455,000 | +12.5% | 9,477 | +5.8% | 0.09% | +2.3% |
| Q3 2019 | $1,293,000 | +1.4% | 8,955 | +0.4% | 0.09% | +2.3% |
| Q2 2019 | $1,275,000 | +2.7% | 8,922 | -5.2% | 0.09% | -1.1% |
| Q1 2019 | $1,242,000 | +24.6% | 9,407 | -2.6% | 0.09% | +10.1% |
| Q4 2018 | $997,000 | +1.6% | 9,663 | +7.1% | 0.08% | +23.4% |
| Q3 2018 | $981,000 | +22.5% | 9,024 | +11.2% | 0.06% | +16.4% |
| Q2 2018 | $801,000 | +9.9% | 8,116 | +9.0% | 0.06% | +7.8% |
| Q1 2018 | $729,000 | +48.5% | 7,448 | +41.0% | 0.05% | +45.7% |
| Q4 2017 | $491,000 | +27.9% | 5,284 | +18.1% | 0.04% | +20.7% |
| Q3 2017 | $384,000 | +68.4% | 4,476 | +86.1% | 0.03% | +26.1% |
| Q1 2016 | $228,000 | -33.3% | 2,405 | -34.6% | 0.02% | -36.1% |
| Q4 2015 | $342,000 | +10.7% | 3,679 | +1.3% | 0.04% | +2.9% |
| Q3 2015 | $309,000 | -5.5% | 3,630 | -5.1% | 0.04% | +2.9% |
| Q2 2015 | $327,000 | -4.4% | 3,824 | -5.0% | 0.03% | -5.6% |
| Q1 2015 | $342,000 | -0.9% | 4,026 | 0.0% | 0.04% | -5.3% |
| Q4 2014 | $345,000 | +14.6% | 4,026 | +1.6% | 0.04% | +11.8% |
| Q3 2014 | $301,000 | -2.9% | 3,963 | +0.6% | 0.03% | 0.0% |
| Q2 2014 | $310,000 | +9.9% | 3,938 | +5.0% | 0.03% | +6.2% |
| Q1 2014 | $282,000 | -8.4% | 3,750 | -5.8% | 0.03% | -11.1% |
| Q4 2013 | $308,000 | +49.5% | 3,983 | +21.8% | 0.04% | +38.5% |
| Q2 2013 | $206,000 | – | 3,269 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |